Abstract

Abstract In response to pathogens, especially viruses, cells release interferons and other cytokines to fight the infections. Interferons are typically divided into three types: I (e.g., INF-α, IFN-β), II (e.g., IFN-γ), and III (e.g., IFN-λ1, IFN-λ2). All interferons are important for fighting viral infections and for regulating the immune system. In addition, interferons are critically involved in cancer and autoimmune diseases such as psoriasis, systemic lupus erythematosus, and multiple sclerosis. Expression profiling of interferons and other related cytokines is critical in achieving a deeper understanding of the immune responses and various disease processes. We have developed a multiplex Human Interferon Panel, using fluorescence-encoded beads that are suitable for use on various flow cytometers. This panel allows simultaneous quantification of 13 cytokines involved in anti-virus responses including interferons (α, β, γ, λ1 and λ2), interleukins (1β, 6, 8, 10, 12), TNF-α, IP-10 and GM-CSF. Each antibody pair was carefully selected for assay specificity, sensitivity, accuracy and reproducibility. The panel has been validated by detecting expected changes in biological samples. Further advantages include high sensitivity, small sample volume, flexible assay configurations, and time- and cost-effectiveness. The Interferon Panel can be used for serum, plasma, cell culture supernatant and other sample types, offering a useful tool for biomedical research and drug discovery.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.